Orano Med Inaugurates Expansion of its U.S. Research and Development Center in Texas
'The expansion of our R&D center enhances our ability to develop lead-212-based radioligand therapies by giving our teams the resources they need to advance a growing pipeline of drug candidates through to the clinic."
Share
With an investment of over $5 million, Orano Med has expanded its R&D Center by approximately 11,000 ft². The expansion includes around 5,000 ft² of new laboratory space, enabling the advancement of a growing pipeline and doubling the Good Manufacturing Practice (GMP) production capacity for early clinical trial supply. In addition, about 5,500 ft² of new office space has been added to accommodate the site's growing team, whose headcount has doubled over the past four years. Overall, this represents about a 50% increase in space compared to the pre-existing facility.
Julien Torgue, Chief Scientific Officer of Orano Med, stated:
'The expansion of our R&D center enhances our ability to develop lead-212-based radioligand therapies by giving our teams the resources they need to advance a growing pipeline of drug candidates through to the clinic. With an integrated platform, cutting-edge equipment and a focused scientific strategy, we are well positioned to support both our internal developments and collaborations with partners.'
Orano Med's R&D platform is fully integrated, combining cutting-edge equipment and a highly experienced team to advance the development of next-generation cancer therapies. The company can carry out the full range of preclinical development studies, including in vivo and Chemistry, Manufacturing and Controls (CMC) studies, onsite. Orano Med conducts both in-house research programs and collaborative developments with biotech and pharmaceutical partners. This integrated approach ensures a rapid and reliable transition from research to clinical phases. While the primary mission of the research and development center is therapeutic development, the facility also serves as production hub for lead-212 based drug candidates for early-stage clinical trials in the U.S.
This expansion demonstrates Orano Med's strong commitment to innovation and leadership in the field of radioligand therapies, accelerating the development of new treatment options for patients worldwide.
A celebration was held on-site with local teams and Orano Med's Executive Committee to mark this important milestone. During the event, Orano Med also unveiled the new name of the facility: Drug Development and Preclinical Unit (DDPU) – George de Hevesy Center
Arnaud Lesegretain, President and Chief Executive Officer of Orano Med, added:
'This expansion marks an important step in Orano Med's growth at our Plano site, which has played a key role since the inception of the company 15 years ago. It reinforces our world-class R&D capabilities in the U.S. and strengthens our ability to deliver innovative targeted alpha therapies by supporting early-stage development in a fully integrated environment.'
About Orano Med
Orano Med, a subsidiary of the Orano Group, is a clinical-stage biotechnology company which develops a new generation of targeted therapies against cancer using the unique properties of lead-212 (212 Pb), an alpha-emitting radioisotope and one of the more potent therapeutic payloads against cancer cells known as Targeted Alpha-Emitter Therapy (TAT). AlphaMedix, its most advanced asset in clinical development for GEP-NETs tumors, received Breakthrough Designation from the FDA in 2024. The company is advancing several potential treatments using 212 Pb combined with various targeting agents through clinical and preclinical studies. Orano Med has 212 Pb manufacturing facilities, laboratories, and R&D centers in France and in the US. It is expanding its GMP-manufacturing capacities for 212 Pb radiolabeled pharmaceuticals in North America and Europe and building a unique, independent, and fully integrated industrial platform to serve the needs of patients globally. For more information, please visit: http://www.oranomed.com
About Orano
As a recognized international leading operator in the field of nuclear materials, Orano delivers solutions to address present and future global energy and health challenges. Its expertise and mastery of cutting-edge technologies enable Orano to offer its customers high value-added products and services throughout the entire fuel cycle. Every day, the Orano group's 17,500 employees draw on their skills, unwavering dedication to safety and constant quest for innovation, with the commitment to develop know-how in the transformation and control of nuclear materials, for the climate and for a healthy and resource-efficient world, now and tomorrow.
Orano, giving nuclear energy its full value.
About Targeted Alpha Therapy
Targeted alpha therapy (TAT) relies on a simple concept: combining the ability of biological molecules to target cancer cells with the short-range cell-killing capabilities of alpha-emitting radioisotopes. Alpha decay consists of the emission of a helium nucleus (alpha particle) together with very high linear energy transfer and a range emission of only few cell layers, resulting in irreparable double strand DNA breaks in cells adjacent only to area of alpha emission. This approach results in an increased cytotoxic potential toward cancer cells while limiting toxicity to nearby healthy cells. As a result, alpha emitters are considered as the most powerful payloads to be found for targeted therapies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Statistics don't support UW-Milwaukee shuttering materials engineering program
Everything is made from something. The materials we use are so important that entire eras of human history are named for them: Stone Age, Bronze Age, Iron Age. The knowledge of how to make, process, and use these materials is fundamental to any form of society. A society that fails to pass this knowledge on to new generations will not survive or prosper. That's why it was disappointing to hear outgoing UWM Chancellor Mark Mone double down on the proposed closure of UWM's award-winning Materials Engineering program. This program provides students with life-changing opportunities for high-paying careers in an in-demand field. It's also critical for our region's manufacturing industry and national defense. Mone pointed to the relatively small size of the Materials Engineering program. He would be hard-pressed to find a school of engineering anywhere in the country in which materials engineering is not the smallest department in terms of number of students. Materials engineering programs typically have dozens of students, not hundreds. To put this into perspective, however, the Bureau of Labor Statistics predicts an average of just 10 job openings per year for neurologists in Wisconsin. Hopefully, no one would suggest that UW-Madison should stop training neurology residents, since most of us recognize that medical specialists are essential to the kind of society we want to have. Materials engineers are no less essential, but since we work behind the scenes, many people are unaware of the critical role we play. In fact, our work goes into every single manufactured item you see around you, from nuts and bolts to airplanes, and everything in between. Letters: Lack of state support, Republicans are to blame for UWM's budget constraints Chancellor Mone suggested redirecting resources towards UWM's Computer Science program. However, unemployment among computer science graduates is currently 6.1% — nearly 1.5 times the overall national average. While computer science is undoubtedly an important field, increasing the present oversupply of computer science graduates will not benefit students or Wisconsin's economy. Materials engineering graduates, in contrast, have an unemployment rate of just 1.85%, and Wisconsin manufacturers are struggling to fill materials engineering positions as the current generation retires. This critical shortage is why the Department of Defense created the METAL (Metallurgical Engineering Trades Apprenticeship & Learning) program, an initiative focused on rebuilding the materials engineering workforce. Given Wisconsin's position as the number one state for metal casting employment, the Defense Department has identified Milwaukee as a target location for a new $1.5 million METAL hub. Opinion: We asked readers about wake boats on Wisconsin lakes. Here's what you said. Funding from this initiative could be a tremendous catalyst to strengthen and grow UWM's Materials Engineering program. This would be a rare win-win-win-win situation: for UWM, for students, for industry, and for national defense. In order to qualify for this funding, however, UWM needs to continue to have a Materials Engineering program. UWM's incoming chancellor, Thomas Gibson, successfully worked with industry in his previous role to ensure UW-Stevens Point's offerings were aligned with workforce needs. Let's hope he brings that perspective to his new role at UWM. Outgoing Chancellor Mone has handed him an awesome opportunity to show that he is a different kind of leader who will take UWM in a new direction. By saving the UWM Materials Engineering program, the new chancellor has a chance to create a tremendous success story that will benefit our region for generations to come. Dave Palmer is a metallurgical engineer at Twin Disc in Racine. He earned his masters degree in Materials Engineering from UWM in 2014, and is currently working on a PhD in Materials Engineering at UWM. This article originally appeared on Milwaukee Journal Sentinel: UWM materials engineering program must be saved from closure | Opinion
New York Times
3 hours ago
- New York Times
Caught Between Tariffs and China, Mexico Adapts to an Unpredictable U.S.
The factory in northern Mexico was built to supply Americans. Just a few hours from Texas, about 80 percent of its air-conditioners and refrigeration units are sent to the United States. President Trump's tariffs threatened to upend its whole business — at least until the company devised a plan. Before the tariffs took effect in March, only about 40 percent of its exports traded under the rules of a pact Mr. Trump signed in his first term. But when Mr. Trump agreed to suspend tariffs on any Mexican goods that fell under the agreement, the company's leaders saw ways to adapt. They sought out Mexican suppliers for products bound for the United States. They analyzed which products already complied with the pact's rules but had not yet been certified as such. And they reconsidered projects that involved bringing in imports from outside North America. 'When you're on a plane and there's turbulence, you get really scared and you hold onto your seat,' said Xavier Casas, who oversees the factory for the company Danfoss, in the Mexican city of Apodaca. 'But, you know, 99 percent of the time, the plane is going to land.' Want all of The Times? Subscribe.
Business Wire
5 hours ago
- Business Wire
MiLi Gears Up for Amazon Prime Day with Exclusive Deals on the MiTag Duo & LiTag Duo for Travel Gadgets Up To 30% Off
SHENZHEN, China--(BUSINESS WIRE)--MiLi is kicking off its biggest summer sale for Prime Day, July 8–11, with major discounts on all Bluetooth trackers. Available across Europe and North America, these deals are perfect for travelers, pet owners, and busy professionals. Buy multi-packs for extra savings! What to Expect from MiLi on Prime Day Products: MiTag Duo and LiTag Duo (Apple Find My and Google Find Hub compatible) Prime Day Highlight: Early bird deals all over Europe and North America already show bundles down 30%! Purchase the 4-pack (MiTag Duo, LiTag Duo) for even steeper discounts. Seamless Delivery Across 12 European Stores Thanks to Amazon's logistics network, Prime members in the UK (England), France, Germany, Italy, Spain, Poland, Sweden, Turkey, Austria, Belgium, the Netherlands, Ireland, Japan, United States, and Canada will enjoy same day or next day fulfilment. 'Prime Day is more than a sale—it's when millions of travellers plan the tools that will accompany them for the next 12 months,' quotes Andy Wang, Head of Sales from MiLi. 'Whether you're protecting your bag with MiTag or dropping LiTags in a luggage, we're thrilled to bring the peace of mind of real time tracking to even more European and North American customers at the best prices of the year.' Key Prime Day Facts (2025) Timing: July 8 – 11th Access: Deals are exclusive to Prime members; new shoppers can start a free 30 day trial to participate About The Products MiTag Duo MiTag Duo is a IP67 waterproof pocket-sized tracker for your keys, bag, or suitcase that makes lost items a thing of the past. It works with Apple Find My and Google Find Hub to show live location and plays a loud chime when nearby. LiTag Duo LiTag Duo packs MiTag's advanced tracking technology into a compact design, seamlessly snapping into AirTag key rings and Apple accessories—plus, it comes with an AirTag holder. Locate it via Apple Find My or Google Find Hub—up to 500 ft (150 m)—or just ask your voice assistant. It is also IP67 waterproof, supports sharing with friends, and keeps your data safe with end-to-end encryption. The only difference between MiTag Duo & LiTag Duo is the size: MiTag Duo: 3.8 x 3.8 x 0.9 mm LiTag Duo: 3.2 x 3.2 x 0.8 mm (same as AirTag) About MiLi Founded in 2003, MiLi blends minimalist design with advanced wireless technology to create everyday accessories that solve modern travel pains—from lost luggage to forgotten keys. MiLi's products are certified for both Apple Find My and Google Find Hub networks and are distributed in 50+ countries through their Shopify website ( Amazon stores, across 100+ airlines, and retail partners.
